236 related articles for article (PubMed ID: 34304992)
1. Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States.
Burton BK; Ellis AG; Orr B; Chatlani S; Yoon K; Shoaff JR; Gallo D
Mol Genet Metab; 2021; 134(1-2):182-187. PubMed ID: 34304992
[TBL] [Abstract][Full Text] [Related]
2. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
3. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
4. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
5. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
6. Early miglustat therapy in infantile Niemann-Pick disease type C.
Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
9. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.
Patterson MC; Vecchio D; Prady H; Abel L; Wraith JE
Lancet Neurol; 2007 Sep; 6(9):765-72. PubMed ID: 17689147
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
[TBL] [Abstract][Full Text] [Related]
11. Miglustat therapy in a case of early-infantile Niemann-Pick type C.
Usui M; Miyauchi A; Nakano Y; Nakamura S; Jimbo E; Itamura S; Adachi K; Nanba E; Narita A; Yamagata T; Osaka H
Brain Dev; 2017 Nov; 39(10):886-890. PubMed ID: 28587793
[TBL] [Abstract][Full Text] [Related]
12. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
[TBL] [Abstract][Full Text] [Related]
13. Possible genotype-phenotype correlations in Niemann-Pick type C patients and miglustat treatment.
Çakar NE; Önal H
Ideggyogy Sz; 2021 Mar; 74(3-4):139-144. PubMed ID: 33938663
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.
Colaco A; Kaya E; Adriaenssens E; Davis LC; Zampieri S; Fernández-Suárez ME; Tan CY; Deegan PB; Porter FD; Galione A; Bembi B; Dardis A; Platt FM
J Inherit Metab Dis; 2020 May; 43(3):574-585. PubMed ID: 31707734
[TBL] [Abstract][Full Text] [Related]
15. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
[TBL] [Abstract][Full Text] [Related]
16. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
Pérez-Poyato MS; Gordo MM; Marfa MP
Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
Lewis C; Keage M; Watanabe M; Schubiger D; Velakoulis D; Walterfang M; Vogel AP
Dysphagia; 2021 Jun; 36(3):362-373. PubMed ID: 32562141
[TBL] [Abstract][Full Text] [Related]
18. [Niemann-Pick type C disease and psychosis: Two siblings].
Maubert A; Hanon C; Metton JP
Encephale; 2015 Jun; 41(3):238-43. PubMed ID: 25238906
[TBL] [Abstract][Full Text] [Related]
19. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C.
Alavi A; Nafissi S; Shamshiri H; Nejad MM; Elahi E
Mol Genet Metab; 2013; 110(1-2):139-44. PubMed ID: 23791309
[TBL] [Abstract][Full Text] [Related]
20. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
